Literature DB >> 1527991

Myelin turnover in hyperphenylalaninaemia. A re-evaluation with the HPH-5 mouse.

F A Hommes1, L Moss.   

Abstract

Myelin turnover has been studied in the 25-day-old HPH-5 mouse, a phenylalanine hydroxylase-deficient mouse mutant. The half-life of the fast component of myelin decreased from 15 days in control mice to 4.5 days at blood phenylalanine levels of 2.5 mmol/L. The slow component of myelin seems also to be affected by the high phenylalanine level. These observations confirm similar observations obtained with chemically induced models of hyperphenylalaninaemia and are therefore due to the hyperphenylalaninaemia per se, independently of the inhibitors of phenylalanine hydroxylase. An intermediate blood level of phenylalanine (0.7 mmol/L) likewise seems to interfere with myelin metabolism, although to a lesser degree.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527991     DOI: 10.1007/bf01799638

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  On a possible mechanism of abnormal brain development in experimental hyperphenylalaninemia.

Authors:  F A Hommes; K Matsuo
Journal:  Neurochem Int       Date:  1987       Impact factor: 3.921

Review 2.  On the mechanism of permanent brain dysfunction in hyperphenylalaninemia.

Authors:  F A Hommes
Journal:  Biochem Med Metab Biol       Date:  1991-12

3.  Turnover of myelin proteins in mouse brain in vivo.

Authors:  A Lajtha; J Toth; K Fujimoto; H C Agrawal
Journal:  Biochem J       Date:  1977-05-15       Impact factor: 3.857

4.  Myelination in rat brain: method of myelin isolation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

5.  Free amino acid pool in the brain of mice homozygous for the gene "dilute lethal".

Authors:  S Simler; S Essayag; M Ledig; C Koehl; P Mandel
Journal:  J Neurosci Res       Date:  1977       Impact factor: 4.164

6.  Brain protein and myelin metabolism in hyperphenylalaninemic rats.

Authors:  R Berger; J Springer; F A Hommes
Journal:  Cell Mol Biol Incl Cyto Enzymol       Date:  1980

7.  Physical growth in phenylketonuria: I. A retrospective study.

Authors:  V A Holm; W E Knox
Journal:  Pediatrics       Date:  1979-05       Impact factor: 7.124

8.  Intelligence and quality of dietary treatment in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

9.  Chronic hyperphenylalaninemia produces cerebral hyperglycinemia in immature rats.

Authors:  G A Dienel
Journal:  J Neurochem       Date:  1981-01       Impact factor: 5.372

10.  Effect of experimental hyperphenylalaninemia on myelin metabolism at later stages of brain development.

Authors:  E H Taylor; F A Hommes
Journal:  Int J Neurosci       Date:  1983-09       Impact factor: 2.292

View more
  3 in total

1.  Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria.

Authors:  M D Phillips; P McGraw; M J Lowe; V P Mathews; B E Hainline
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

2.  Different degrees of white matter abnormalities in untreated phenylketonurics: findings in magnetic resonance imaging.

Authors:  J Weglage; G Schuierer; G Kurlemann; R Bick; K Ullrich
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  The effect of hyperphenylalaninaemia on the muscarinic acetylcholine receptor in the HPH-5 mouse brain.

Authors:  F A Hommes
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.